← Back to Search

Arteriovenous Graft (AVG) for Arteriovenous Fistula

N/A

Waitlist Available

Led By Theodore Yuo, MD MSc

Research Sponsored by University of Pittsburgh

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

Study Summary

This trial will test whether it is feasible and safe to randomize patients over 65 years old who start hemodialysis with a tunneled dialysis catheter (TDC) to an arteriovenous fistula (AVF) strategy or to an arteriovenous graft (AVG) strategy. The primary outcome is feasibility, which will be assessed by measuring the proportion of randomized participants who receive the assigned arteriovenous access and the annual rate of enrollment in the study.

Eligible Conditions

Arteriovenous Graft
Arteriovenous Fistula
Kidney Failure

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Proportion of subjects that received assigned AV access (AVF vs. AVG)

Secondary outcome measures

Rate of accrual of subjects to the study

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Arteriovenous Graft (AVG)Active Control1 Intervention

If the participant is randomized to the AVG arm of the trial, the surgeon will place a synthetic graft connecting an artery and vein under the skin in an upper extremity.

Group II: Arteriovenous Fistula (AVF)Placebo Group1 Intervention

If the participant is randomized to the AVF arm of the trial, the surgeon will connect an artery to a vein in the upper extremity, without using artificial material as conduit.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor

1,720 Previous Clinical Trials

16,342,790 Total Patients Enrolled

Theodore Yuo, MD MSc4.01 ReviewsPrincipal Investigator - University of Pittsburgh

University of Pittsburgh

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities available for participants to join this trial?

"Absolutely. According to clinicaltrials.gov, this study is actively recruiting participants as of August 8th 2022, with the original posting date being September 14th 2018. The researchers are planning on enrolling 50 patients from a single medical site."

Answered by AI

How many participants are recruited for this research endeavor?

"Indeed, the data available on clinicaltrials.gov denotes that this medical study is currently recruiting patients. This trial was initially published on September 14th 2018 and has been recently updated on August 8th 2022. The researchers are searching for 50 participants from one site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Trial of Fistula Versus Graft in Elderly Patients

Theodore Yuo 2018. "Trial of Fistula Versus Graft in Elderly Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03668002.